Copyright
©The Author(s) 2020.
World J Clin Oncol. Dec 24, 2020; 11(12): 1018-1028
Published online Dec 24, 2020. doi: 10.5306/wjco.v11.i12.1018
Published online Dec 24, 2020. doi: 10.5306/wjco.v11.i12.1018
Variables | Levels | Total, n % |
Age | mean ± SD | 48.28 ± 11.83 |
Region | Punjab | 88 (88.0%) |
Khyber Pakhtunkhwa | 7.0 (7.0%) | |
Kashmir | 3.0 (3.0%) | |
Sindh | 2.0 (2.0%) | |
Histology | Ductal | 91 (91.0%) |
Others | 9.0 (9.0%) | |
Grade | II | 35 (35.0%) |
III | 56 (56.0%) | |
UNK | 09 (9.0%) | |
Tumor size | T1 | 7.0 (7.0%) |
T2/T3 | 57 (57.0%) | |
UNK | 36 (36.0%) | |
Nodes | Negative | 37 (37.0%) |
Positive | 50 (50.0%) | |
UNK | 13 (13.0%) | |
Metastasis | Negative | 38 (38.0%) |
Positive | 49 (49.0%) | |
UNK | 13 (13.0%) | |
Estrogen receptor | Negative | 69 (69.0%) |
Positive | 31 (31.0%) | |
Progesterone receptor | Negative | 74 (74.0%) |
Positive | 26 (26.0%) | |
HER2 status | Negative | 74 (74.0%) |
Positive | 26 (26.0%) | |
TNBC | No | 51 (51.0%) |
Yes | 49 (49.0%) | |
Status | Alive | 50 (50.0%) |
Death | 35 (35.0%) | |
Lost to follow-up | 15 (15.0%) | |
FOXP3 | Negative | 75 (75.0%) |
Positive | 25 (25.0%) | |
IDO score | Low | 24 (24.0%) |
Medium | 27 (27.0%) | |
High | 49 (49.0%) |
- Citation: Asghar K, Loya A, Rana IA, Bakar MA, Farooq A, Tahseen M, Ishaq M, Masood I, Rashid MU. Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients. World J Clin Oncol 2020; 11(12): 1018-1028
- URL: https://www.wjgnet.com/2218-4333/full/v11/i12/1018.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i12.1018